Jubilant Cadista Recalls Pantoprazole Sodium Tablets Due to Manufacturing Deviations
Jubilant Cadista Pharmaceuticals is recalling specific lots of Pantoprazole Sodium Delayed Release Tablets because they were not manufactured in accordance with Good Manufacturing Practices.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to cGMP deviations, which typically indicates a remote possibility of temporary or medically reversible health consequences, fitting the Moderate severity criteria for manufacturing issues without reported specific injuries.
Plain-English summary
Jubilant Cadista Pharmaceuticals Inc. is recalling 12,770 bottles of Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count. The affected products are identified by Lot PA22028 and Lot PA22029, both with an expiration date of 5/2014. The NDC number for the product is 59746-284-90.
The recall was initiated because the oral products were not manufactured in accordance with Good Manufacturing Practices (cGMP). The agency has classified this recall as Class II.
The affected products were distributed nationwide. Consumers should check their medication for the specific lot numbers and expiration dates listed above. If you have the affected product, you should stop using it and contact your healthcare provider or pharmacist for guidance on obtaining a replacement.
The recalled product
- Product
- Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90
- Manufacturer
- Jubilant Cadista Pharmaceuticals Inc.
- Category
- Drug — Oral Solid Dosage
- Hazard
- Affected units
- 12,770
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot PA22028 Exp 5/2014 Lot PA22029 Exp 5/2014
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Jubilant Cadista Pharmaceuticals Inc.
See all →- Moderate
- HighIrbesartan Blood Pressure Tablets Recalled Due to Failed Dissolution
FDA (Drugs) · 2022-08-03
- HighJubilant Cadista Irbesartan tablets recalled due to failed dissolution
FDA (Drugs) · 2022-08-03
- ModerateFDA Voluntary Recall of Methylprednisolone Tablets for Subpotency
FDA (Drugs) · 2022-04-13
- SevereMeclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up
FDA (Drugs) · 2022-04-06
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14